Expression of Hepatocyte Growth Factor-Like Protein Is Repressed by Retinoic Acid and Enhanced by Cyclic Adenosine 3′,5′-Monophosphate Response Element-Binding Protein (CREB)-Binding Protein (CBP)1
In an effort to understand the molecular mechanisms involved in the regulation of expression of the gene encoding hepatocyte growth factor-like protein (HGFL), it was found that all-trans-retinoic acid dramatically represses expression of the endogenous HGFL gene in HepG2 cells, a human hepatocyte-d...
Gespeichert in:
Veröffentlicht in: | Endocrinology (Philadelphia) 1999-01, Vol.140 (1), p.187-196 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In an effort to understand the molecular mechanisms involved in the
regulation of expression of the gene encoding hepatocyte growth
factor-like protein (HGFL), it was found that
all-trans-retinoic acid dramatically represses
expression of the endogenous HGFL gene in HepG2 cells, a human
hepatocyte-derived cell line. This repression requires the sequence
between nucleotides −135 and −105 in the 5′-flanking sequence of the
HGFL gene, a site that has previously been shown to bind the
transcription factor hepatocyte nuclear factor-4 (HNF-4).
Electrophoretic mobility shift analysis suggests that the retinoic acid
receptor does not bind to this site, and that retinoic acid does not
alter binding of HNF-4 to this DNA site. However, the transcriptional
coactivator, CREB-binding protein (CBP) coactivates expression of this
gene through an indirect interaction with the HNF-4-binding site, and
overexpression of CBP in HepG2 cells eliminates retinoic acid
repression of reporter gene expression driven by the HGFL promoter.
Overexpression of CBP also protects the endogenous HGFL gene from
down-regulation by retinoic acid. These results suggest that HGFL gene
expression requires CBP, and competition for limiting amounts of CBP by
retinoic acid receptor may be a means of modifying the activity of
HNF-4 at the HGFL gene promoter. |
---|---|
ISSN: | 0013-7227 1945-7170 |
DOI: | 10.1210/endo.140.1.6441 |